Claims
- 1. A method for recovery of a concentrated protein or biomolecule of interest from the interstitial fluid of a plant tissue comprising the steps of:
(a) infiltrating a plant tissue with a buffer solution; (b) subjecting the plant tissue and buffer solution to a substantially vacuum environment; (c) removing the tissue from the buffer solution; (d) centrifuging the tissue to remove interstitial fluid; and (e) concentrating the protein or biomolecule of interest from the interstitial fluid; wherein said plant tissue is in the quantity of kilograms.
- 2. The method of claim 1, wherein said tissue is centrifuged in a basket centrifuge.
- 3. The method of claim 1, wherein the protein or biomolecule is concentrated by means of ultra filtration.
- 4. The method of claim 1, wherein the protein or biomolecule is concentrated by means of expanded bed chromatography.
- 5. The method according to claim 1, wherein the plant tissue is selected from the group consisting of: leaves, stems, shoots, flowers, fruit and roots.
- 6. The method according to claim 5, further comprising the step of dissecting the plant leaf substantially along the midrib before infiltrating the plant leaf with a buffer solution.
- 7. The method of claim 1, wherein the buffer solution is selected from the group consisting of: Citrate, Phosphate and Tris.
- 8. The method of claim 7, wherein the buffer solution contains detergents selected from the group consisting of sodium laurocholate, SDS, t-octylphenoxypolyethoxyethanol, fatty acid esters of polyoxyethylenesorbitan, phospholipids, bile salts, sodium deoxycholate and sodium lauryl sulfate.
- 9. The method of claim 7, wherein the buffer solution contains chelators selected from the group consisting of: EDTA, EGTA and citrate.
- 10. The method of claim 7, wherein the buffer solution contains antioxidants selected from the group consisting of: α-mercapto ethanol, ascorbate, sodium metabisulfate and dithiothreitol.
- 11. The method of claim 5, wherein the plant leaf and buffer solution are subjected to a vacuum pressure of about 200 up to 760 mm Hg.
- 12. The method of claim 11, wherein the vacuum pressure is about 400 up to 760 mm Hg.
- 13. The method of claim 12, wherein the vacuum pressure is about 740 up to 760 mm Hg.
- 14. The method of claim 13, wherein the vacuum pressure is about 760 mm Hg.
- 15. The method of claim 1, wherein the centrifugation is conducted at a G-force range of 50-5,000×G.
- 16. The method of claim 15, wherein the centrifugation is conducted at a G-force range of about 2,000×G.
- 17. The method of claim 1, wherein the protein of interest is produced in the plant by a recombinant plant viral vector.
- 18. The method of claim 1, wherein the protein of interest is produced by a transgenic plant.
- 19. The method of claim 1, wherein the protein of interest is produced naturally in the plant.
- 20. The method of claim 1, further comprising the step of draining or blotting excess buffer from the tissue before centrifuging.
- 21. The method of claim 1, further comprising the step of transferring the tissue from the buffer solution to the centrifuge by means of a discontinuous batch process.
- 22. The method of claim 1, further comprising the step of substantially purifying a protein of interest from the tissue remaining after the interstitial fluid has been removed by centrifugation.
- 23. The method of claim 1, wherein the protein is derived from cellular components selected from the group consisting of: the plasma transmembrane, peroxisomes, associated membranes, other organelles, the nucleus, the Golgi apparatus, the cytosol, the rough and smooth endoplasmic reticulum, the mitochondria, the vacuole and the chloroplast.
- 24. The method of claim 1, wherein the protein of interest is a ribosome inactivating protein.
- 25. The method of claim 1, wherein the protein of interest is a human lysosomal enzyme.
- 26. The method of claim 1, wherein the protein of interest is an industrial enzyme.
- 27. The method of claim 1, wherein the protein of interest is a cytokine.
- 28. The method of claim 1, wherein the protein of interest is an antibody or antibody fragment.
- 29. The method of claim 1, wherein the protein of interest is α-galactosidase or an isozyme of α-galactosidase.
- 30. The method of claim 1, wherein the protein of interest is glucocerebrosidase or an isozyme of glucocerebrosidase.
- 31. The method of claim 1, wherein the protein of interest also comprises a signaling peptide to direct the protein to a specific compartment within a cell.
- 32. The method of claim 1, wherein more than one type of protein can be simultaneously purified.
- 33. The method according to claim 1, wherein said infiltration is a continuous infiltration by means of a cylindrical pressure vessel containing an internal auger with a rotary inlet and a rotary discharge valve.
- 34. A method according to claim 2, wherein said basketcentrifuge is capable of being accelerated to recover IF at about 2000-2500×G and leaf material is discharged through a split rotor design.
Parent Case Info
[0001] This application is a continuation of U.S. application Ser. No. 09/726,648, filed Nov. 28, 2000; which is a continuation of U.S. application Ser. No. 09/500,554, filed Feb. 9, 2000, now U.S. Pat. No. 6,284,875; which is a continuation of U.S. application Ser. No. 09/132,989, filed Aug. 11, 1998, now abandoned.
Continuations (3)
|
Number |
Date |
Country |
Parent |
09726648 |
Nov 2000 |
US |
Child |
10119330 |
Apr 2002 |
US |
Parent |
09500554 |
Feb 2000 |
US |
Child |
10119330 |
Apr 2002 |
US |
Parent |
09132989 |
Aug 1998 |
US |
Child |
10119330 |
Apr 2002 |
US |